Manage Disease Without Waiting For LabWork


BreviTest has been broadly recognized for its exceptional technology and promising impact in the medical field.


SBIR Awards

BreviTest has won Small Business Innovation Research Grants (SBIR) from the National institute on Drug Abuse (2016) and Department of Health and Human Services (2017)


Texas New Ventures Prize winner

In 2015, Brevitest was awarded a prize at the inaugural Texas New Ventures Competition (TNVC) sponsored by Texas A&M University. BreviTest was selected for a prize form a group of 91 eligible contestants and was recognized for its potential global impact in the medical field.

AACC Semi-Finalist

BreviTest (far left) was named a semi-finalist in the AACC’s first ever disruptive technology competition. Being a semi-finalist BreviTest was asked to present as a keynote technology at the 70th annual clinical lab expo in Chicago. This technology exposition is the largest in the world for clinical laboratory products and services, and included over 860 presenting companies.



BreviTest works with a variety of credited institutions to bring cutting-edge and reliable technology to the medical field.

Baylor College of MEdicine

BreviTest has partnered with the Baylor College of Medicine (BCM) to develop and test tropical disease testing.

Center For Disease Control

BreviTest is not limited to common disease and testing and has partnered with the Center for Disease Control (CDC) to accommodate for Ebola testing.

Texas Children’s Hospital

BreviTest has a developed partnership with Texas Children’s Hospital (TCH) and is collaborating with TCH to improve pediatric methotrexate testing.